All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ADIAL PHARMACEUTICALS, INC.: Last Reported 3/31/2020

Business Address

1180 SEMINOLE TRAIL
SUITE 495
CHARLOTTESVILLE, VA US 22902

Mailing Address

1180 SEMINOLE TRAIL
SUITE 495
CHARLOTTESVILLE, VA US 22902
Phone Number: 434-422-9800 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 12/31/2016
Cash and Cash Equivalents $4,951,631.00 $6,777,052.00 $8,529,681.00 $10,254,023.00 $11,394,244.00 $3,869,043.00 $4,816,705.00 $150,026.00 $53,967.00 $18,248.00 $40,350.00 $137,134.00 $87,993.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $240,382.00 $359,499.00 $510,879.00 $155,207.00 $279,422.00 $317,547.00 $428,594.00 $30,044.00 -- $9,000.00 -- -- --
Total Current Assets $5,935,207.00 $7,673,467.00 $9,500,615.00 $10,680,917.00 $12,053,336.00 $4,692,550.00 $5,245,299.00 $180,070.00 -- $27,248.00 -- -- --
Property Plant and Equipement -- -- -- -- -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $6,029.00 $6,170.00 $6,311.00 $6,452.00 $6,593.00 $6,735.00 $6,875.00 $7,017.00 -- $7,298.00 -- -- --
Total Assets $5,941,236.00 $7,679,637.00 $9,506,926.00 $10,687,369.00 $12,059,929.00 $4,699,285.00 $5,252,174.00 $187,087.00 -- $34,546.00 -- -- --
Accounts Payable -- $190,204.00 $475,086.00 -- -- $99,671.00 -- -- -- -- -- -- --
Accrued Liabilities $193,447.00 $348,847.00 -- -- -- $158,303.00 -- -- -- -- -- -- --
Total Current Liabilities -- -- -- -- -- -- -- -- -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-22,903,612.00 $-20,626,799.00 $-18,568,311.00 $-16,852,428.00 $-14,718,021.00 $-12,035,370.00 $-10,766,222.00 $-2,575,298.00 -- $-403,992.00 -- -- --
Total Stockholders' Equity $5,551,407.00 $7,140,586.00 $8,729,980.00 $10,060,816.00 $11,730,737.00 $4,441,311.00 $4,929,368.00 $-1,293,517.00 $-1,307,342.00 $-997,553.00 -- -- $-103,493.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $5,941,236.00 $7,679,637.00 $9,506,926.00 $10,687,369.00 $12,059,929.00 $4,699,285.00 $5,252,174.00 $187,087.00 -- $34,546.00 -- -- --

Statement of Operations

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 12/31/2016
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $1,054,609.00 $3,965,543.00 $864,280.00 $1,897,350.00 $686,914.00 $368,459.00 $188,435.00 $132,403.00 $55,508.00 $182,107.00 $27,797.00 $57,863.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $2,300,245.00 $8,244,900.00 $1,745,742.00 $4,408,276.00 $2,249,266.00 $6,987,222.00 $3,816,099.00 $2,080,980.00 $339,513.00 $995,286.00 $673,492.00 $411,085.00 --
Loss from Operations $-2,300,245.00 $-8,244,900.00 $-1,745,742.00 $-2,159,010.00 $-2,249,266.00 $-6,987,222.00 $-5,897,079.00 $-2,080,980.00 $-339,513.00 $-995,286.00 $-262,416.00 $-411,085.00 --
Loss Before Income Taxes $-2,276,813.00 $-8,591,429.00 $-6,532,941.00 $-4,817,058.00 $-2,682,651.00 $-11,631,378.00 $-8,190,924.00 $-2,171,306.00 $-378,950.00 $-1,139,456.00 $-292,626.00 $-442,838.00 --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- 482,555 243,182 -- -- 174,282 174,282 -- -- --
Common Stock Shares Authorized 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 -- 50,000,000 -- -- --
Common Stock Shares Outstanding 10,629,603 10,368,352 10,294,860 10,242,449 10,168,826 6,862,499 6,556,249 3,560,314 -- 3,268,005 -- -- --
Copyright 2020 PursePoor.com